Personalized Glycated Hemoglobin in Diabetes Management: Closing the Gap with Glucose Management Indicator-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Personalized Glycated Hemoglobin in Diabetes Management: Closing the Gap with Glucose Management Indicator

Published:2023-06-01 Issue:S3 Volume:25 Page:S-65-S-74
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Dunn Timothy C.¹,Xu Yongjin¹,Bergenstal Richard M.²^ORCID,Ogawa Wataru³,Ajjan Ramzi A.⁴

Affiliation:

1. Clinical Affairs, Abbott Diabetes Care, Alameda, California, USA.

2. International Diabetes Center, HealthPartners Institute, Minneapolis, Minnesota, USA.

3. Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, Kobe, Japan.

4. The LIGHT Laboratories, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2023.0146

Reference54 articles.

1. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

2. 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

3. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview

4. Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

5. Translating the A1C Assay Into Estimated Average Glucose Values

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intermittently Scanned Continuous Glucose Monitoring Performance in Patients With Liver Cirrhosis;Journal of Diabetes Science and Technology;2024-03-04

2. Is It Time to Move Beyond TIR to TITR? Real-World Data from Over 20,000 Users of Continuous Glucose Monitoring in Patients with Type 1 and Type 2 Diabetes;Diabetes Technology & Therapeutics;2024-03-01

3. Closed-Loop Control, Artificial Intelligence–Based Decision-Support Systems, and Data Science;Diabetes Technology & Therapeutics;2024-03-01

4. Estimating Glycemia From HbA1c and CGM: Analysis of Accuracy and Sources of Discrepancy;Diabetes Care;2024-02-23

5. The Glucose Management Indicator: Time to Change Course?;Diabetes Care;2024-01-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3